Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study.

Peyronnet, Benoit

Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study. [electronic resource] - Neurourology and urodynamics 03 2017 - 734-739 p. digital

Publication Type: Journal Article

1520-6777

10.1002/nau.23009 doi


Administration, Intravesical
Adult
Botulinum Toxins, Type A--administration & dosage
Case-Control Studies
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged
Neuromuscular Agents--administration & dosage
Retrospective Studies
Treatment Outcome
Urinary Bladder, Neurogenic--drug therapy
Urinary Bladder, Overactive--drug therapy
Urodynamics--drug effects